期刊文献+

基于AllinOne合成模块的雌激素受体显像剂^(18)F-FES自动化合成 被引量:1

Automated synthesis of photographic developer ^(18)F-FES of estrogen receptor based on ALLinOne
在线阅读 下载PDF
导出
摘要 目的:应用AllinOne合成模块自动化合成雌激素受体(ER)显像剂16α-氟18(^(18)F)-17β-雌二醇(^(18)F-FES),为^(18)F-FES在临床中的进一步应用提供支持。方法:采用AllinOne合成模块,以3-O-(甲氧甲基)-16,17-O-磺酰基-16-表雌二醇(MMSE)为前体,与干燥后的^(18)F-发生亲核反应,再依次经酸水解及碱中和,经过高效液相色谱(HPLC)法分离并纯化后获得^(18)F-FES产品,并进行质量控制检测。结果:在^(18)F-FES的合成中,合成时间为70 min,6次合成不校正合成平均效率为(38.87±3.52)%,产品放射化学纯度>98%,无菌检测、细菌内毒素检测、异常毒性检测及残留溶剂乙腈含量检测结果均符合《中华人民共和国药典》(2020年版)要求。结论:应用AllinOne合成模块成功地自动化合成了ER受体显像剂^(18)F-FES,制备出的^(18)F-FES产品质量符合临床要求,为推动^(18)F-FES在临床上的应用提供了支持。 Objective:To apply AllinOne synthesis module in automatic synthesizing photographic developer 16α-Fluorine18(^(18)F)-17β-estradiol(^(18)F-FES)of estrogen receptor(ER)so as to provide support for the further application of ^(18)F-FES in clinical practice.Methods:AllinOne synthesis module was adopted,and 3-O-methoxymethyl-16,17-O-sulfuryl-16-epiestriol(MMSE)was used as the precursor to react with dried ^(18)F ion as nucleophilic reaction.And they underwent successively acid hydrolysis and neutralization with NaOH.And then,the high performance liquid chromatography(HPLC)was used to separate and purify the reaction mixture,and the ^(18)F-FES was obtained finally.The corresponding test of quality controls of the product ^(18)F-FES were performed.Results:In the synthesis of ^(18)F-FES,the synthesized time was 70 min,and synthesized average efficiency of 6 syntheses without rectification was(38.87%±3.52)%,radiochemistry purity of the product was over 98%.The results of sterility test,bacterial endotoxins test,abnormal toxicity test and the content of residual solvent acetonitrile all met the requirements of Chinese Pharmacopoeia(2020 Edition).Conclusion:The ER receptor photographic developer ^(18)F-FES was successfully automatically synthesized by using AllinOne synthesis module.The product quality of produced ^(18)F-FES meets the clinical requirements,which provides support for promoting the clinical application of ^(18)F-FES.
作者 黄政海 任超 霍力 HUANG Zheng-hai;REN Chao;HUO Li(HTA Co.,Ltd.,Beijing 102413,China;不详)
出处 《中国医学装备》 2022年第2期31-35,共5页 China Medical Equipment
基金 清华大学-北京协和医院合作课题(PTQH201906006)“PET/CT介导消融手术机器人关键技术研究及样机研制”。
关键词 雌激素受体 16α-氟18(^(18)F)-17β-雌二醇(^(18)F-FES) 自动化合成 AllinOne合成模块 显像剂 Estrogen receptor(ER) 16α-Fluorine18(^(18)F)-17β-estradiol(^(18)F-FES) Automated synthesis Allin One synthesis module Photographic developer
  • 相关文献

参考文献7

二级参考文献80

  • 1孟洁,郎荣刚,范宇,付丽.年轻乳腺癌患者的病理学和生物学特征及其与预后的关系[J].中华肿瘤杂志,2007,29(4):284-288. 被引量:29
  • 2Yu K D, Di G H, Wu J, et aL Ann Surg Oncol, 2007, 14(9): 2502-2509.
  • 3Pujol P, Hilsenbeck S G, Chamness G C, et al. Cancer, 1994, 74(5): 1601-1606.
  • 4Guadagnoli E, Shapiro C, Gurwitz J H, et al. J Clin Oncol, 1997, 15(6): 2338-2344.
  • 5Mortimer J E, Dehdashti F, Siegel B A, et al. J Clin Oncol, 2001, 19(11): 2797-2803.
  • 6Kumar P, Mercer J, Doerkson C, et al. J Pharm Pharmaceut Sci, 2007, 10(2): 256s-265s.
  • 7McGuire A H, Dehdashti E Siegel B A, et al.J Nucl Med 1991, 32(8): 1526-1531.
  • 8Buck A K, Schirrmeister H, Mattfeldt T, et al. Eur J Nucl Med Mol Imaging, 2004, 31(S1): S80-S87.
  • 9Yoshida Y, Kurokawa T, Sawamura Y, et al. Gynecol Oncol, 2007, 104(3): 764-766.
  • 10Tsuchida T, Okazawa H, Mori T, et al. Nucl Med Biol 2007, 34(2): 205-210.

共引文献27

同被引文献3

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部